03-08-2025 00:53 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Sun Pharmaceutical Industries Ltd.
Change Company   
BSE Code 524715
ISIN Demat INE044A01036
Book Value 104.58
NSE Code SUNPHARMA
Dividend Yield % 0.98
Market Cap 3908636.63
P/E 81.46
EPS 20.00
Face Value 1  
01-Aug-2025 Clarification sought from Sun Pharmaceutical Ind...
31-Jul-2025 Sun Pharmaceutical Industries reports 20% fall in...
21-Jul-2025 Sun Pharmaceutical Industries informs about pres...
18-Jul-2025 Sun Pharma incorporates subsidiary company in Chi...
15-Jul-2025 Sun Pharmaceutical Industries launches LEQSELVI i...
15-Jul-2025 Sun Pharmaceutical Industries gains on launching ...
14-Jul-2025 Sun Pharma Advanced Research Company informs abou...
25-Jun-2025 Sun Pharma’s partner withdraws application for ma...
25-Jun-2025 Sun Pharmaceutical Industries informs about inve...
25-Jun-2025 Sun Pharma gains on the BSE
14-Jun-2025 USFDA conducts GMP inspection of Sun Pharma’s Hal...
26-May-2025 Sun Pharmaceutical Industries to invest up to $25...
23-May-2025 Sun Pharmaceutical Industries reports 19% fall in...
24-Apr-2025 Sun Pharmaceutical Industries informs about press...
14-Apr-2025 Sun Pharmaceutical Industries’ arm recalls around...
Page 1 of 3
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.